Search





Search





Markets
/
Stocks
/
nasdaq-med
/

Medifast Inc

MED

Add to Watchlist

12.480USD

-0.100-0.79%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

138.77MMarket Cap

LossP/E TTM



Medifast Inc

12.480

-0.100-0.79%

Overview Financials Discussions Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Medifast Inc

Currency: USD Updated: 2026-05-15

Key Insights

Medifast Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 38 out of 95 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 12.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Medifast Inc's Score

Industry at a Glance

Industry Ranking

38 / 95

Overall Ranking

191 / 4482

Industry

Food & Tobacco

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Medifast Inc Highlights

StrengthsRisks

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD .

Undervalued

The company’s latest PE is -6.85, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 9.25M shares, decreasing 32.05% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 780.61K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.22.

Analyst Rating

Based on 2 analysts

Hold

Current Rating

12.000

Target Price

-4.69%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Medifast Inc is 6.70, ranking 55 out of 95 in the Food & Tobacco industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 76.04M, representing a year-over-year decrease of 34.29%, while its net profit experienced a year-over-year decrease of 174.87%.

Score

Industry at a Glance

Previous score

6.70

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.75

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.48

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.44

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

4.84

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Medifast Inc's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Medifast Inc is 8.68, ranking 12 out of 95 in the Food & Tobacco industry. Its current P/E ratio is -6.85, which is -7989.61% below the recent high of 540.21 and -222.59% above the recent low of -22.09.

Score

Industry at a Glance

Previous score

8.68

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 38/95

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

The current earnings forecast score of Medifast Inc is 6.00, ranking 56 out of 95 in the Food & Tobacco industry. The average price target is 15.00, with a high of 15.00 and a low of 15.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Hold

Current Rating

12.000

Target Price

-4.69%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Medifast Inc

MED

Mondelez International Inc

MDLZ

Hershey Co

HSY

Kraft Heinz Co

KHC

Campbell's Co

CPB

General Mills Inc

GIS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Medifast Inc is 6.79, ranking 43 out of 95 in the Food & Tobacco industry. Currently, the stock price is trading between the resistance level at 13.97 and the support level at 10.46, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.81

Change

-0.02

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.137

Buy

RSI(14)

64.736

Neutral

STOCH(KDJ)(9,3,3)

73.872

Neutral

ATR(14)

0.654

High Vlolatility

CCI(14)

48.243

Neutral

Williams %R

27.073

Buy

TRIX(12,20)

0.796

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

12.504

Sell

MA10

12.414

Buy

MA20

11.673

Buy

MA50

10.797

Buy

MA100

10.936

Buy

MA200

11.871

Buy

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Medifast Inc is 7.00, ranking 24 out of 95 in the Food & Tobacco industry. The latest institutional shareholding proportion is 83.21%, representing a quarter-over-quarter decrease of 2.48%. The largest institutional shareholder is James Simons, holding a total of 773.71K shares, representing 6.96% of shares outstanding, with 13.96% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

832.84K

-0.55%

Renaissance Technologies LLC

Star Investors

780.61K

-2.53%

Charles Schwab Investment Management, Inc.

776.83K

+30.51%

Steamboat Capital Partners LLC

657.59K

+137.90%

Dimensional Fund Advisors, L.P.

326.24K

+9.34%

Lido Advisors, LLC

330.70K

Geode Capital Management, L.L.C.

247.45K

-3.36%

Chard (Daniel R)

176.94K

+7.27%

Numeric Investors LLC

236.50K

+10.81%

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Tobacco domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Medifast Inc is 5.66, ranking 48 out of 95 in the Food & Tobacco industry. The company's beta value is 0.63. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.